Plenco 466-100
Product Description
Plenco 466-100 was a phenolic molding compound manufactured by Plastics Engineering Company, commonly known as Plenco, a Wisconsin-based specialty chemicals and plastics manufacturer. Phenolic compounds of this type — sometimes referred to as phenol-formaldehyde resins or Bakelite-class materials — were widely used across American industry throughout much of the twentieth century due to their exceptional heat resistance, electrical insulating properties, and dimensional stability under mechanical stress.
Molding compounds like Plenco 466-100 were engineered for use in applications where components needed to withstand high temperatures, corrosive environments, or repeated mechanical loading. These properties made phenolic compounds broadly attractive to manufacturers producing electrical components, automotive parts, industrial hardware, and other durable goods. The finished material could be compression-molded, transfer-molded, or injection-molded into a wide variety of forms, including housings, bushings, handles, panels, and structural insulating parts.
Plenco, as a company, offered an extensive line of phenolic and other thermosetting compounds under various product designations. The 466-100 designation indicates a specific formulated grade within their phenolic compound line, likely differentiated by filler content, cure characteristics, or performance specifications suited to particular end-use requirements. The exact years during which Plenco 466-100 was produced have not been conclusively established in publicly available documentation, though phenolic compounds of this class were commonly manufactured and sold from the mid-twentieth century onward, with asbestos-filled grades remaining in production until regulatory pressure mounted during the 1970s and 1980s.
Asbestos Content
Phenolic molding compounds manufactured during much of the twentieth century frequently incorporated asbestos fibers as a functional filler and reinforcing agent. Asbestos — particularly chrysotile and, in some formulations, amphibole varieties — was valued in thermoset plastics because it improved the compound’s mechanical strength, reduced shrinkage during cure, enhanced heat resistance, and contributed to the electrical insulating performance of finished components.
Litigation records document allegations that Plenco 466-100 contained asbestos as a component of its formulation. Plaintiffs alleged that asbestos fibers were incorporated into this phenolic compound as a filler material, consistent with industry-standard practices for thermosetting molding compounds of that era. The specific fiber type, concentration, and the precise formulation details of Plenco 466-100 as they relate to asbestos content have been subjects of legal and technical dispute in personal injury proceedings.
It is well established through historical industry documentation that many phenolic compounds sold under various trade designations routinely contained asbestos fiber content ranging from minor percentages up to substantial proportions of total weight, depending on the intended application. Regulatory records, including documentation developed under the Asbestos Hazard Emergency Response Act (AHERA) framework and OSHA’s asbestos standards, confirm that asbestos-filled molding compounds were a recognized occupational hazard category requiring specific engineering controls and exposure monitoring.
How Workers Were Exposed
Exposure to asbestos from phenolic molding compounds like Plenco 466-100 could occur at multiple points across the industrial supply chain — from compounding and processing facilities through to end-use manufacturing environments and maintenance operations.
Compounding and Handling of Raw Material: Workers involved in receiving, weighing, and blending raw phenolic compound materials before molding operations could encounter airborne asbestos fibers if the compound was dusty or if bags or containers were opened and handled in enclosed spaces. Dry phenolic compound in powder or granule form prior to molding presented a particular inhalation risk if asbestos fibers were present.
Molding Operations: Industrial workers operating compression or transfer molding presses were potentially exposed during loading of the compound into molds, trimming of flash from finished parts, and routine press maintenance. The heat and pressure involved in the molding process could generate particulate emissions, and trimming or deflashing operations on cured phenolic parts could release dust containing embedded asbestos fibers.
Machining and Finishing: Post-molding operations including drilling, grinding, cutting, sanding, and buffing of phenolic components could liberate asbestos fibers from the cured matrix in significant concentrations. Workers performing these operations in manufacturing settings — often without adequate respiratory protection, particularly prior to the tightening of OSHA asbestos standards in the 1970s and 1980s — faced repeated and potentially high-level exposures.
Maintenance and Custodial Workers: Individuals responsible for cleaning work areas where phenolic compound dust accumulated, or for maintaining and repairing equipment used in processing operations, may also have experienced incidental exposure.
Litigation records document claims by industrial workers generally who alleged occupational exposure to asbestos through contact with Plenco 466-100 and similar phenolic molding compounds during the ordinary course of their employment. Plaintiffs alleged that this exposure occurred without adequate warning of the known health risks associated with asbestos inhalation, and that prolonged or repeated contact contributed to the development of serious asbestos-related diseases including mesothelioma, asbestosis, and lung cancer.
Documented Trust Fund / Legal Options
Plenco 466-100 is classified as a Tier 2 — Litigated Product, meaning that legal claims associated with this product have proceeded through the civil tort system rather than through an established asbestos bankruptcy trust fund. As of available documentation, Plastics Engineering Company has not established or contributed to a dedicated asbestos claims resolution trust of the type created under Section 524(g) of the U.S. Bankruptcy Code.
Civil Litigation: Litigation records document personal injury and wrongful death lawsuits filed by former industrial workers and their families alleging asbestos-related disease caused by exposure to Plenco 466-100 and other Plenco phenolic compounds. Plaintiffs alleged that the manufacturer knew or should have known of the hazards associated with asbestos-containing products and failed to provide adequate warnings or instructions for safe handling. These cases have proceeded in state and federal courts across the United States.
Other Trust Fund Eligibility: Individuals diagnosed with mesothelioma, asbestosis, lung cancer, or other asbestos-related conditions who worked with Plenco 466-100 may have been exposed to asbestos from multiple products and manufacturers across their working lives. Exposure to raw asbestos supplied by third-party companies, or to other asbestos-containing products used alongside Plenco compounds in the same work environment, may support separate claims against additional defendants or eligible asbestos bankruptcy trusts. A qualified asbestos attorney can conduct a full occupational exposure assessment to identify all applicable legal avenues.
Consulting Legal Counsel: Anyone diagnosed with an asbestos-related disease who has a work history involving phenolic molding compounds, including Plenco 466-100, should consult with an attorney experienced in asbestos litigation. Statutes of limitations vary by state and begin running from the date of diagnosis or discovery of disease, making timely consultation important to preserving legal rights.
This article is provided for informational and reference purposes only. It is based on publicly available litigation records, regulatory documentation, and historical industry information. It does not constitute legal advice. Individuals seeking guidance on specific legal claims should consult a licensed attorney.